Clinical Trial Update: Safety and Effectiveness of an Immunobiological Drug in CoViD-19 [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 clinical trial update reports on the safety and effectiveness of an immunobiological drug for COVID-19 pneumonia and respiratory infection; cu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• COVID-19 Pneumonia
• COVID-19 Respiratory Infection

Snippet

Sponsor: Administracion Nacional de Laboratorios e Institutos de Salud Dr. Carlos G. Malbran | Conditions: COVID-19 Pneumonia, COVID-19 Respiratory Infection | Phase 2, Phase 3 | Status: UNKNOWN